Infections Staphylococcal Infections

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Staphylococcal Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Staphylococcal Infections Projects
--AstraZeneca Plc
--Inhibitex Inc
--Intercell AG
--Merck & Co Inc
--Nabi Biopharmaceuticals
--Novartis AG
--WOCKHARDT LIMITED

--Top Companies in early stage Staphylococcal Infections Projects
--aRigen Pharmaceuticals, Inc.
--Affinium Pharmaceuticals, Inc.
--AstraZeneca Plc
--Arpida Ltd.
--Cytogenix Inc
--CrystalGenomics, Inc.
--ImmuPharma plc
--EluSys Therapeutics, Inc.
--Intercell AG
--Inhibitex Inc
--Janus Pharmaceuticals Inc
--INTRACEL Corp
--NanoBio Corporation
--Nabi Biopharmaceuticals
--Optimer Pharmaceuticals, Inc.
--Nymox Pharmaceutical Corporation
--Prolysis Limited
--Pfizer Inc
--Wyeth
--Syntopix Group plc

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View